Clinical trial · Interventional
Augmented Reality Navigation System (Endosight) for the Guidance of Bone Biopsy
Assessment of Operative Time, Precision, and Safety of an Augmented Reality Navigation System (Endosight) for the Guidance of Bone Biopsy
NCT05732558CI-TRIAL-00064578completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical study is to evaluate the duration of the procedure, the precision (distance between the needle tip and the centre of the target), and the safety of endosight system in the guidance for bone biopsies.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bone Infection | — | UNRESOLVED | — |
| Bone Lesion | — | UNRESOLVED | — |
| Bone Tumor | Bone Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 8 Patients who were prescribed a CT-guided percutaneous bone biopsy, performed with the aid of endosight navigation system | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- prospective
- description
- 8 Patients who were prescribed a CT-guided percutaneous bone biopsy, performed with the aid of endosight navigation system
- interventionNames
- Procedure: 8 Patients who were prescribed a CT-guided percutaneous bone biopsy, performed with the aid of endosight navigation system
- type
- NO_INTERVENTION
- label
- retrospective
- description
- 8 Patients with a bone lesion for which a percutaneous biopsy has been performed from January 2011 to May 2022
Primary outcomes (2)
- measure
- Procedure time
- timeFrame
- During bone biopsy procedure (after the bone sample has been collected)
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient with a bone lesion for which a percutaneous biopsy is indicated; * Informed consent signed by the patient for participation in the study. Exclusion Criteria: * Age \< 18 years; * Pregnant and lactating women (assessed through auto declaration of the patient)
References
Publications (1)
- DERIVEDAlbano D, Messina C, Gitto S, Chianca V, Sconfienza LM. Bone biopsies guided by augmented reality: a pilot study. Eur Radiol Exp. 2023 Jul 20;7(1):40. doi: 10.1186/s41747-023-00353-w. PMID 37468652